These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24574150)

  • 21. Feasibility of rapidly assessing reactive impurities mediated excipient incompatibility using a new method: A case study of famotidine-PEG system.
    Saraf I; Modhave D; Kushwah V; Neshchadin D; Gescheidt G; Trausinger G; Melchior P; Magnes C; Paudel A
    J Pharm Biomed Anal; 2020 Jan; 178():112893. PubMed ID: 31606565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel.
    Liu J; Zahedi P; Zeng F; Allen C
    J Pharm Sci; 2008 Aug; 97(8):3274-90. PubMed ID: 18064681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods.
    Huynh L; Grant J; Leroux JC; Delmas P; Allen C
    Pharm Res; 2008 Jan; 25(1):147-57. PubMed ID: 17705028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
    Liu F; Feng L; Zhang L; Zhang X; Zhang N
    Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compounding with Silicones.
    Allen LV
    Int J Pharm Compd; 2015; 19(3):223-30. PubMed ID: 26714363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
    Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment.
    Cho JK; Hong JM; Han T; Yang HK; Song SC
    J Drug Target; 2013 Jul; 21(6):564-73. PubMed ID: 23594096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a drug to structure its release matrix and release profile.
    Brook MA; Holloway AC; Ng KK; Hrynyk M; Moore C; Lall R
    Int J Pharm; 2008 Jun; 358(1-2):121-7. PubMed ID: 18407444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.
    Yadav S; Gupta S
    Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):93-102. PubMed ID: 24195582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ring.
    Murphy DJ; Amssoms K; Pille G; Clarke A; O'Hara M; van Roey J; Malcolm RK
    Drug Deliv Transl Res; 2016 Jun; 6(3):234-42. PubMed ID: 26787615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silicones as nonocclusive topical agents.
    De Paepe K; Sieg A; Le Meur M; Rogiers V
    Skin Pharmacol Physiol; 2014; 27(3):164-71. PubMed ID: 24457536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
    Zhigaltsev IV; Winters G; Srinivasulu M; Crawford J; Wong M; Amankwa L; Waterhouse D; Masin D; Webb M; Harasym N; Heller L; Bally MB; Ciufolini MA; Cullis PR; Maurer N
    J Control Release; 2010 Jun; 144(3):332-40. PubMed ID: 20202473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A; Shao C; Shen Y; Tu J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.